Halma plc with ticker (LON:HLMA) now has a potential downside of -4.1% according to JP Morgan Cazenove.
HLMA.L
JP Morgan Cazenove set a target price of 2,600 GBX for the company, which when compared to the Halma plc share price of 2,710 GBX at opening today (20/12/2024) indicates a potential downside of -4.1%. Trading has ranged between 2,104 (52 week low) and 2,815 (52 week high) with an average of 681,110 shares exchanging hands daily. The market capitalisation at the time of writing is £10,303,576,156.
Halma plc is a life-saving technology company. Its segments include Safety, Environmental & Analysis and Healthcare. The Safety segment provides products that protect people, property and assets and enable safe movement in public spaces. This segment’s solutions include fire safety, through fire detection and fire suppression solutions; safe movement in public, commercial and industrial spaces; elevator safety, and more. Its Environmental & Analysis segment provides solutions that monitor the environment and improve the availability of life-critical natural resources, such as air, water, and food, and analyze materials in a range of applications. It also manufactures devices for high-precision measurement of trace moisture found in gases. Its Healthcare segment helps healthcare providers to improve the care they deliver. It offers minimally invasive procedures, complementing its products used to diagnose and treat cancer. It also develops, manufactures and supplies medical devices.
Halma plc -4.1% potential downside indicated by JP Morgan Cazenove
- Written by: Charlotte Edwards
Latest Company News
Halma plc has released its interim results for the six months to 30 September 2025, with full details available on its website and through the FCA’s National Storage Mechanism.
Halma plc reported strong progress in the first half of its financial year to 30 September 2025, raising full-year revenue growth guidance to low double-digit organic constant currency growth, up from upper single digits.
Halma Plc has revealed its full-year results for the period ending March 31, 2025, highlighting its commitment to advancing life-saving technologies for a better future.
Halma Plc has appointed Hudson La Force as an independent non-executive Director, effective June 2, 2025, bringing invaluable industrial and international expertise.
Halma Plc (LON:HLMA) reports steady growth ahead of its financial year-end, with improved margin guidance and a strong acquisition pipeline.
Halma plc announces CFO transition with Steve Gunning retiring in 2025 and Carole Cran stepping in, continuing the company's growth strategy.



































